Clinical Trial Update: Sternal Closure With Biologic Bone Cement in Patients Undergoing Coronary Artery Bypass Grafting (CABG) [Phase 4]

View source ↗

Summary

This update describes a Phase 4 clinical trial evaluating sternal closure using biologic bone cement in patients undergoing coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Biologic Bone Cement (bone cement)

Snippet

Sponsor: National University Heart Centre, Singapore | Conditions: Sternal Closure | Phase 4 | Status: UNKNOWN